Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Trump administration advances drug importation plan

Proposal would allow states to import drugs from Canada

- PMLiVE

New hires at Bristol-Myers Squibb, Acceleron and FerGene

The latest movers in pharma

- PMLiVE

AbbVie’s JAK inhibitor Rinvoq approved in EU for rheumatoid arthritis

Continued expansion for next-generation immunology drug

- PMLiVE

Seattle, Astellas bag speedy FDA okay for bladder cancer drug

Plans to expand use into earlier bladder cancer treatment

- PMLiVE

The transatlantic opioid crisis

Could the scale of litigation against so-called ‘Opioid Inc’ reach the heights of those pursued against Big Tobacco?

Basket of fruit

Are supermarkets responsible for public health?

If supermarkets don't shoulder some of the responsiblity for the public health crisis, it'll only get worse. But would they risk the financial impact?

Page & Page Health

Clinical trials, Actually.

This Christmas, we’re thinking of the thousands of clinical trial volunteers across the UK, both patients and healthy participants. We have a lot to thank them for...

Cuttsy + Cuttsy

- PMLiVE

AZ, Merck’s Lynparza narrowly scores FDA approval for pancreatic cancer

Committee voted seven to five in favour of PARP inhibitor

- PMLiVE

FDA panel clears Keytruda for hard-to-treat bladder cancer

New treatment option for high-risk patients

- PMLiVE

Alnylam’s third RNAi drug clears phase 3 trial in rare kidney disease

Plans to file for approval in US and Europe in early 2020

- PMLiVE

A snapshot of Healx

PME talks to CSO Neil Thompson

- PMLiVE

BeiGene’s Brukinsa misses the mark in head-to-head Imbruvica trial

Failed to beat rival in rare white blood cell cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links